UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 23, 2023
Accession Number:
0001104659-23-110512
Submission Type:
POS AM
CIK:
0001541157
Company Name:
Akari Therapeutics Plc
File Number:
333-267840